| MARQONLI BOEHRINGER INGELHEIM INTERNATIONAL GMBH
2279631 18 Jul 2023 | on 06 Sep 2023 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism, namely, renal diseases, liver diseases, pancreas diseases, digestive system disorders, gastrointestinal diseases and disorders, obesity; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the blood and blood forming organs, namely, vascular diseases, hematology, blood disorders; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the cardiovascular diseases and disorders system, musculoskeletal diseases and disorders system, central nervous system diseases and disorders, peripheral nervous system diseases and disorders; pharmaceutical preparations for the prevention and treatment of genitourinary system genitourinary diseases, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for the prevention and treatment of respiratory system; pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, damaged skin and tissues, namely, rashes, sores, psoriasis, eczema; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases and disorders, namely, anti-inflammatories; pharmaceutical preparations for the prevention and treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment and prevention of hormonal diseases and disorders; pharmaceutical preparations for the treatment and prevention of infectious diseases and disorders and viral infections, namely, antibiotics, anti-infectives, antivirals; pharmaceutical preparations for the prevention and treatment of oncological diseases; pharmaceutical preparations for the prevention and treatment of auto-immune diseases and disorders; cell based immune therapeutics for treatment of cancer, treatment of immunological diseases, and treatment of infectious diseases. | |